Last mentioned: Mar 19, 2026
Regulatory Submission
Target window for potential FDA submission for DeepView System clearance.
Data Collection Completion
Expected completion of clinical data collection for burn applications.
Clinical Study Expansion
Commencement of expanded clinical validation studies for burn care.
BARDA Award Announced
Spectral AI receives $31.7M in additional funding for DeepView development.
Spectral AI has been awarded $31.7 million in additional funding from the Biomedical Advanced Research and Development Authority (BARDA) to accelerate the development and clinical validation of its DeepView® System. This non-dilutive capital will support the company's efforts to bring AI-driven diagnostic precision to burn and wound care, particularly for mass casualty scenarios.
This page surfaces every story mentioning DeepView System across our ai coverage. We track each entity's appearance over time so readers can trace how the narrative evolves — which developments are isolated incidents, which build into longer arcs, and which reframe how operators in the space think about the entity. Story selection uses the same multi-source verification gate applied across the rest of our coverage.
Read our editorial methodology for how we identify, deduplicate, and score entity references. Our glossary defines the technical terms used across stories on this page, and our trends index contextualizes individual developments against the longer-running ai beat. Cross-entity comparisons live on our compare view.
| What you see | What it tells you |
|---|---|
| Story count | Number of distinct stories where DeepView System was a primary or referenced actor. |
| Recency clustering | Whether mentions are concentrated in a recent window (a news cycle) or distributed (a sustained arc). |
| Sentiment distribution | Aggregate sentiment of the stories mentioning this entity, weighted by impact score. |
| Cross-niche links | When the same entity surfaces in our sibling networks, we link to those views to enrich context. |